Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF Inhalation.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
2023
Historique:
received: 03 03 2022
accepted: 01 09 2022
pubmed: 13 12 2022
medline: 8 2 2023
entrez: 12 12 2022
Statut: ppublish

Résumé

A previous clinical trial for autoimmune pulmonary alveolar proteinosis (APAP) demonstrated that granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation reduced the mean density of the lung field on computed tomography (CT) across 18 axial slice planes at a two-dimensional level. In contrast, in this study, we challenged three-dimensional analysis for changes in CT density distribution using the same datasets. As a sub-study of the trial, CT data of 31 and 27 patients who received GM-CSF and placebo, respectively, were analyzed. To overcome the difference between various shooting conditions, a newly developed automatic lung field segmentation algorithm was applied to CT data to extract the whole lung volume, and the accuracy of the segmentation was evaluated by five pulmonary physicians independently. For normalization, the percent pixel (PP) in a certain density range was calculated as a percentage of the total number of pixels from -1,000 to 0 HU. The automatically segmented images revealed that the lung field was accurately extracted except for 7 patients with minor deletion or addition. Using the change in PP from baseline to week 25 (ΔPP) as the vertical axis, we created a histogram with 143 HU bins set for each patient. The most significant difference in ΔPP between GM-CSF and placebo groups was observed in two ranges: from -1,000 to -857 and -143 to 0 HU. Whole lung extraction followed by density histogram analysis of ΔPP may be an appropriate evaluation method for assessing CT improvement in APAP.

Sections du résumé

BACKGROUND
A previous clinical trial for autoimmune pulmonary alveolar proteinosis (APAP) demonstrated that granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation reduced the mean density of the lung field on computed tomography (CT) across 18 axial slice planes at a two-dimensional level. In contrast, in this study, we challenged three-dimensional analysis for changes in CT density distribution using the same datasets.
METHODS
As a sub-study of the trial, CT data of 31 and 27 patients who received GM-CSF and placebo, respectively, were analyzed. To overcome the difference between various shooting conditions, a newly developed automatic lung field segmentation algorithm was applied to CT data to extract the whole lung volume, and the accuracy of the segmentation was evaluated by five pulmonary physicians independently. For normalization, the percent pixel (PP) in a certain density range was calculated as a percentage of the total number of pixels from -1,000 to 0 HU.
RESULTS
The automatically segmented images revealed that the lung field was accurately extracted except for 7 patients with minor deletion or addition. Using the change in PP from baseline to week 25 (ΔPP) as the vertical axis, we created a histogram with 143 HU bins set for each patient. The most significant difference in ΔPP between GM-CSF and placebo groups was observed in two ranges: from -1,000 to -857 and -143 to 0 HU.
CONCLUSION
Whole lung extraction followed by density histogram analysis of ΔPP may be an appropriate evaluation method for assessing CT improvement in APAP.

Identifiants

pubmed: 36502800
pii: 000528038
doi: 10.1159/000528038
doi:

Substances chimiques

Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-109

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Miku Oda (M)

Department of Respiratory Medicine, Kyorin University Faculty of Medicine Graduate School of Medicine, Tokyo, Japan, pigumiimaamoset@yahoo.co.jp.

Kentaro Yamaura (K)

Knowledge Mining Laboratory, Information & Management Systems Engineering, Nagaoka University of Technology, Nagaoka, Japan.

Haruyuki Ishii (H)

Department of Respiratory Medicine, Kyorin University Faculty of Medicine Graduate School of Medicine, Tokyo, Japan.

Nobutaka Kitamura (N)

Niigata University Medical and Dental Hospital, Niigata, Japan.

Ryushi Tazawa (R)

Tokyo Medical and Dental University, Health Administration Center Tokyo, Tokyo, Japan.

Mitsuhiro Abe (M)

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Koichiro Tatsumi (K)

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Ryosuke Eda (R)

Kurashiki Municipal Hospital, Kurashiki, Japan.

Shotaro Kondoh (S)

Kurashiki Municipal Hospital, Kurashiki, Japan.

Konosuke Morimoto (K)

Department of Clinical Medicine, Nagasaki University, Institute of Tropical Medicine, Nagasaki, Japan.

Takeshi Tanaka (T)

Department of Clinical Medicine, Nagasaki University, Institute of Tropical Medicine, Nagasaki, Japan.

Etsuro Yamaguchi (E)

Division of Respiratory Medicine and Allergology, Department of Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Ayumu Takahashi (A)

Hakodate National Hospital, Division of Respiratory Medicine, Department of Internal Medicine, Hakodate, Japan.

Shinyu Izumi (S)

Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Haruhito Sugiyama (H)

Department of Respiratory Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Atsushi Nakagawa (A)

Kobe City Medical Center General Hospital, Kobe, Japan.

Keisuke Tomii (K)

Kobe City Medical Center General Hospital, Kobe, Japan.

Masaru Suzuki (M)

Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Satoshi Konno (S)

Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Shinya Ohkouchi (S)

Department of Respiratory, Tohoku University Graduate School of Medicine, Sendai, Japan.

Naoki Tode (N)

Department of Respiratory, Tohoku University Graduate School of Medicine, Sendai, Japan.

Tomohiro Handa (T)

Department of Advanced Medicine for Respiratory Failure and Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Toyohiro Hirai (T)

Department of Advanced Medicine for Respiratory Failure and Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Yoshikazu Inoue (Y)

National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

Toru Arai (T)

National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

Katsuaki Asakawa (K)

Department of Respiratory medicine, Saiseikai Niigata Hospital, Niigata, Japan.

Takahiro Tanaka (T)

Niigata University Medical and Dental Hospital, Niigata, Japan.

Toshinori Takada (T)

Niigata University Medical and Dental Hospital, Niigata, Japan.

Hirofumi Nonaka (H)

Knowledge Mining Laboratory, Information & Management Systems Engineering, Nagaoka University of Technology, Nagaoka, Japan.

Koh Nakata (K)

Niigata University Medical and Dental Hospital, Niigata, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH